This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Stocks Insiders Are Snapping Up

Furiex Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

In the drug development and collaboration complex, insiders have bought up a large amount of stock in is Furiex Pharmaceuticals (FURX), whose product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. Insiders are sniffing out some value here since the stock is off by around 40% in 2011.

Furiex Pharmaceuticals has a market cap of $179.74 million and an enterprise value of $136.81 million. Its estimated growth rate for next year is 74.4%. This is a cash-rich company, with a total cash position of $54.81 million and total debt of just $10 million. After you back out the debt, Furiex's total cash comes to $44.81 million.

A director and beneficial owner just bought 163,342 shares, or about $2.88 million worth of stock, at $17.50 to $17.65 per share. This same director also bought over $5.3 million worth of stock in November.

From a technical standpoint, FURX is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong since its October low of $12.25 a share. During that uptrend, shares have been consistently making higher lows and higher highs, which is bullish. Traders should now watch for a near-term breakout to trigger if you're looking to play this for some quick profits.

If you're bullish on FURX, I would get long once it breaks out above some overhead resistance at $18.50 and $19.26 on heavy volume. (Furiex shows up on a recent list of Stocks Rising on Unusual Volume.) Look for volume that's tracking in close to or above its three-month average action of 69,930 shares. I would then add to any long position once the stock breaks out again over $19.55 to $20 a share on high-volume. That $20 level is all the all-time high on this stock, so it should be considered very bullish once it's taken out with volume.

This stock can also be bought on weakness back toward $17 a share. I would use a mental stop just below the 200-day at $16.09 if you buy off weakness, and simply use a mental stop a few percentage points below $18.50 if you buy off strength.

5 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,904.12 -15.47 -0.09%
S&P 500 1,981.60 +9.86 0.50%
NASDAQ 4,527.5140 +19.2020 0.43%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs